Zacks Investment ResearchThu, 23 Apr 2026 17:36:24 GMTSYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?SYRE+2.66%
Seeking AlphaTue, 14 Apr 2026 11:45:06 GMTSpyre Therapeutics: Strong SPY001 Data Set Up A Catalyst-Rich 2026SYRE+2.66%
Seeking AlphaMon, 13 Apr 2026 19:21:47 GMTSpyre Therapeutics, Inc. (SYRE) Discusses SPY001 Part A Induction Topline Results From SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis TranscriptSYRE+2.66%
BenzingaMon, 13 Apr 2026 17:29:55 GMTSpyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis DrugSYRE+2.66%
The Motley FoolWed, 08 Apr 2026 10:58:09 GMTSpyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data NearsSYRE+2.66%
The Motley FoolThu, 19 Mar 2026 02:34:49 GMTSignal or Noise: What VR Adviser's Spyre Theraputics Buy Means for FoolsSYRE+2.66%
Seeking AlphaTue, 17 Mar 2026 18:18:35 GMTSpyre: 'Strong Buy' As UC Program Moves Along And Q3 2026 RA Data LoomsSYRE+2.66%
Seeking AlphaWed, 11 Mar 2026 05:40:14 GMTSpyre Therapeutics, Inc. (SYRE) Presents at Leerink Global Healthcare Conference 2026 TranscriptSYRE+2.66%
The Motley FoolMon, 23 Feb 2026 15:18:15 GMTSpyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 MillionSYRE+2.66%
